Safety, pharmacokinetics, and antiviral activity of a novel HIV antiviral, ABX464, in treatment-naive HIV-infected subjects in a phase 2 randomized, controlled study

by Steens J., Scherrer D., Gineste P., Barrett P., Khuanchai S., Winai R., Ruxrungtham K., Tazi J., Murphy R., Ehrlich H.
Published 2017

Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine

by Tambyah, P.A., Wilder-Smith, A., Pavlova, B.G., Barrett, P.N., Oh, H.M.L., Hui, D.S., Yuen, K.-Y., Fritsch, S., Aichinger, G., Loew-Baselli, A., van der Velden, M., Maritsch, F., Kistner, O., Ehrlich, H.J.
Published 2016

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture

by Ehrlich, H.J., Berezuk, G., Fritsch, S., Low-Baselli, A., Vartian, N., Bobrovsky, R., Pavlova, B.G., Pollabauer, E.M., Kistner, O., Barrett, P.N., Muller, M., Joukhadar, C., Oh, H.M.L., Tambyah, P.A., Fisher, D., Montomoli, E.
Published 2011

A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responses

by Ehrlich, H.J., Müller, M., Fritsch, S., Zeitlinger, M., Berezuk, G., Löw-Baselli, A., Van Der Velden, M.V.W., Pöllabauer, E.M., Maritsch, F., Pavlova, B.G., Tambyah, P.A., Oh, H.M.L., Montomoli, E., Kistner, O., Noel Barrett, P.
Published 2016